---
$id: https://graph.org.ai/products/commodity/51322205
$type: Product
source: UNSPSC
code: "51322205"
title: "Rosuvastatin calcium"
class: "51322200"
classTitle: "Antihyperlipidemic and hypocholesterolemic azetidines and cyclohexanes and fluorobenzenes and furans"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rosuvastatin calcium

**UNSPSC Code**: 51322205
**Class**: [Antihyperlipidemic and hypocholesterolemic azetidines and cyclohexanes and fluorobenzenes and furans](Antihyperlipidemic and hypocholesterolemic azetidines and cyclohexanes and fluorobenzenes and furans.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a hmg-coa reductase inhibitor with the molecular formula 2C22H27FN3O6S.CA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83MVU38M7Q. European Medicines Agency schedules rosuvastatin calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20721. The term rosuvastatin calcium is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule rosuvastatin calcium under HS 29350090 and SITC 51580. As of Q4 2014, ROSUVASTATIN CALCIUM remains US FDA's Preferred Term for this commodity. Rosuvastatin calcium bears US NLM identifiers UMLS ID C1101751 and NCI Concept Code C61933. SMILES: CC(C1NC(NC(C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2CCC(CC2)F)N(S(=O)(=O)C)C)C.CC(C1NC(NC(C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2CCC(CC2)F)N(S(=O)(=O)C)C)C.[CA+2].

